Palvella Therapeutics (PVLA) Non-Current Assets (2013 - 2026)

Palvella Therapeutics (PVLA) has 13 years of Non-Current Assets data on file, last reported at $528000.0 in Q1 2026.

• On a quarterly basis, Non-Current Assets changed N/A year-over-year to $528000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 283.28% increase from a year earlier, with the FY2025 full-year figure at $572000.0, changed N/A from the prior year.
• Non-Current Assets for Q1 2026 stood at $528000.0, down from $572000.0 in the prior quarter.
• Over the last five years, Non-Current Assets for PVLA reached as high as $25.4 million in Q1 2022 and fell as low as $287000.0 in Q3 2023.
• Historically, Non-Current Assets has averaged $15.1 million across 4 years, with a median of $21.1 million in 2023.
• Across the five-year window, Non-Current Assets dropped 7.81% in 2022 and plunged 98.61% in 2023, its largest moves.
• Year by year, Non-Current Assets stood at $22.1 million in 2022, then slumped by 98.7% to $287000.0 in 2023, then surged by 99.3% to $572000.0 in 2025, then declined by 7.69% to $528000.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $528000.0 in Q1 2026, $572000.0 in Q4 2025, and $287000.0 in Q3 2023.